2021-000244-21 MITO 35a: a multicenter, prospective, single arm trial of
Olaparib maintenance therapy in newly diagnosed BRCA wildtype advanced ovarian, fallopian tube and primitive peritoneal cancer.
MITO 35a: a multicenter, prospective, single arm trial of
Olaparib maintenance therapy in newly diagnosed BRCA wildtype advanced ovarian, fallopian tube and primitive peritoneal cancer.
date_time
2022-07-13 12:12:00
Codice EUDRACT
2021-000244-21
Promotore
Istituto Nazionale per la Cura dei Tumori-Fondazione G.Pascale